Evaluating the Potential for CAR T Cells as Treatment of Solid Tumors
Prasad S. Adusumilli, MD, FACS, discusses the potential role of chimeric antigen receptor T-cell therapy as treatment of solid tumors now that they have demonstrated safety and efficacy in some Hematologic Malignancies.
Expert Addresses Role of CAR T-Cell Therapy in Solid Tumors
Prasad S. Adusumilli, MD, FACS, discusses where he sees chimeric antigen receptor T-cell therapy fitting into the treatment landscape for patients with solid tumors.
2 Clarke Drive Cranbury, NJ 08512